Table 5 Intermediate precision of Ivacaftor in mobile phase and human plasma
S. no. | Conc (μg/mL) | Mobile phase | Human plasma | ||||
|---|---|---|---|---|---|---|---|
Conc found (μg/mL) | % | Avg % | Conc found (μg/mL) | % | Avg% | ||
1 | 45 | 46.53 | 103.4 | 99.15 | 45.94 | 102.0 | 101.7 |
2 | 44.6 | 99.1 | 46.01 | 102.2 | |||
3 | 44.26 | 98.3 | 45.68 | 101.5 | |||
4 | 44.54 | 98.9 | 45.71 | 101.5 | |||
5 | 43.84 | 97.4 | 45.72 | 101.6 | |||
6 | 44.04 | 97.8 | 45.68 | 101.5 | |||
S.D | 0.396 | 0.13 | |||||
% R.S.D | 0.8 | 0.28 | |||||